CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 100 enrolled
Drug / intervention
Bupivacaine Hydrochloridedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04814537
NCT04814537Phase 4Completed
CompareCT.gov

A Trial to Determine the Optimal Bupivacaine Dose for Initiation of Labor Epidural Pain Relief

Brigham and Women's Hospital·interventional·Posted Mar 24, 2021·Updated Aug 4, 2022

In Brief

A Phase 4 clinical trial evaluating Bupivacaine Hydrochloride for Labor Pain and Analgesia. Completed, enrolled 100 participants across 1 site.

Detailed Summary

To estimate the dose of bupivacaine required to achieve initial effective comfort in 90% of patients (ED90) via the epidural (DPE or EPL) technique in women undergoing labor.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLabor Pain, Analgesia
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20222023202420252026
First PostedMar 24, 2021
Enrollment StartFeb 25, 2021
Primary CompletionMar 23, 2022
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 5.3 years ago

Interventions

Bupivacaine Hydrochloridedrug

Local Anesthetic Agent